To further investigate whether leptin could be a survival factor for BC cells treated with chemotherapeutics, TNBC cell lines that differentially respond to chemotherapeutics were treated with paclitaxel, cisplatin, leptin, and leptin signaling inhibitors (peptides and shRNA). The gene discussed is LEP; the disease is breast cancer.